MENU
IMTX
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
941.46M
52 days until earnings call
IMTX
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
941.46M
IMTX Immatics NV Chart, History Price & Graph
a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer
Industry Biotechnology
GET INTRADAY SIGNALS
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
IMTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with FATE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then FATE could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To IMTX | 1D Price Change % | ||
|---|---|---|---|---|
| IMTX | 100% | -1.18% | ||
| FATE - IMTX | 41% Loosely correlated | -3.65% | ||
| CYTK - IMTX | 36% Loosely correlated | -0.93% | ||
| KNSA - IMTX | 35% Loosely correlated | -2.92% | ||
| AUTL - IMTX | 31% Poorly correlated | -12.36% | ||
| SNPX - IMTX | 31% Poorly correlated | +30.17% | ||
More | ||||
Groups containing IMTX
Correlation & Price change
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To IMTX | 1D Price Change % |
|---|---|---|
| IMTX | 100% | -1.18% |
| germany (undefined stocks) | 67% Closely correlated | -0.05% |
| therapeutic (undefined stocks) | 48% Loosely correlated | +3.30% |
| cancer (undefined stocks) | 36% Loosely correlated | -1.34% |
| biopharmaceutical (undefined stocks) | 36% Loosely correlated | -2.96% |
| treatment (undefined stocks) | 32% Poorly correlated | -1.42% |